Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Cranford, NJ
SEC filing record 1 source field available
Fiscal year end
30 September
Citius Pharmaceuticals, Inc. has filed 630 SEC EDGAR filings since 23 Nov 2010

SEC filing history

Showing 401-425 of 630 matching filings.

Per page
25
Current page
17
DEF 14A File 001-38174

DEFINITIVE PROXY STATEMENT

Filing date
20 Dec 2018
Reporting date
13 Feb 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38174

CURRENT REPORT

Filing date
12 Dec 2018
Reporting date
11 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 001-38174

ANNUAL REPORT

Filing date
11 Dec 2018
Reporting date
30 Sep 2018
Next action
Verify source filing
4

4 filing

Filing date
06 Sep 2018
Reporting date
04 Sep 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
06 Sep 2018
Reporting date
04 Sep 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
06 Sep 2018
Reporting date
04 Sep 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
06 Sep 2018
Reporting date
04 Sep 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
06 Sep 2018
Reporting date
04 Sep 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
06 Sep 2018
Reporting date
04 Sep 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
06 Sep 2018
Reporting date
04 Sep 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
06 Sep 2018
Reporting date
04 Sep 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-90253

SCHEDULE 13D

Filing date
27 Aug 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-90253

SCHEDULE 13D

Filing date
27 Aug 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-90253

SC 13G filing

Filing date
20 Aug 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
15 Aug 2018
Reporting date
13 Aug 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
15 Aug 2018
Reporting date
13 Aug 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-38174

QUARTERLY REPORT

Filing date
14 Aug 2018
Reporting date
30 Jun 2018
Next action
Verify source filing
8-K File 001-38174

CURRENT REPORT

Filing date
13 Aug 2018
Reporting date
09 Aug 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
424B4 File 333-226395

PROSPECTUS

Filing date
10 Aug 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-226395

EFFECT filing

Filing date
08 Aug 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
06 Aug 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
06 Aug 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1/A File 333-226395

AMENDMENT NO. 1 TO REGISTRATION STATEMENT

Filing date
06 Aug 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
03 Aug 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38174

CURRENT REPORT

Filing date
01 Aug 2018
Reporting date
01 Aug 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .